HCA Healthcare, Inc. $HCA Shares Purchased by Sagespring Wealth Partners LLC

Sagespring Wealth Partners LLC increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,140 shares of the company’s stock after purchasing an additional 769 shares during the period. Sagespring Wealth Partners LLC’s holdings in HCA Healthcare were worth $3,885,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Morningstar Investment Management LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter worth $665,000. Cornerstone Wealth Group LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter worth $232,000. NorthRock Partners LLC lifted its stake in shares of HCA Healthcare by 4.1% in the 2nd quarter. NorthRock Partners LLC now owns 2,234 shares of the company’s stock worth $856,000 after acquiring an additional 89 shares during the period. Verdence Capital Advisors LLC lifted its stake in shares of HCA Healthcare by 6.5% in the second quarter. Verdence Capital Advisors LLC now owns 20,843 shares of the company’s stock valued at $7,985,000 after purchasing an additional 1,274 shares during the period. Finally, Sequoia Financial Advisors LLC lifted its stake in shares of HCA Healthcare by 41.4% in the second quarter. Sequoia Financial Advisors LLC now owns 4,559 shares of the company’s stock valued at $1,747,000 after purchasing an additional 1,334 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $410.71 on Tuesday. The company has a market cap of $96.10 billion, a PE ratio of 17.26, a price-to-earnings-growth ratio of 1.31 and a beta of 1.40. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $439.01. The company has a 50-day simple moving average of $406.07 and a 200-day simple moving average of $376.56.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. During the same period last year, the company earned $5.50 earnings per share. The company’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s payout ratio is currently 12.11%.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. The Goldman Sachs Group set a $470.00 price objective on shares of HCA Healthcare in a research note on Tuesday. KeyCorp raised their price objective on shares of HCA Healthcare from $370.00 to $465.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Bank of America raised their target price on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a report on Wednesday, September 10th. UBS Group set a $465.00 target price on shares of HCA Healthcare in a report on Wednesday, October 8th. Finally, Barclays raised their target price on shares of HCA Healthcare from $390.00 to $445.00 and gave the company an “overweight” rating in a report on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $425.71.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.